Author details

Full Name

Kan V Lu

Affiliation

Clinical Medical Research Center of Hepatic Surgery at Hubei Province

ORCID

Career Start Year

1995

Papers

H Index

Expertise

CM4AI Collaborator

Andrej Sali (CM4AI)

PMID	Paper Title	Journal Title	Published Year
35089546	Discoidin domain receptor 1 promotes hepatocellular carcinoma progression through modulation of SLC1A5 and the mTORC1 signaling pathway.	Cell Oncol (Dordr)	2022
36100865	TRIM proteins in hepatocellular carcinoma.	J Biomed Sci	2022
30202050	A tension-mediated glycocalyx-integrin feedback loop promotes mesenchymal-like glioblastoma.	Nat Cell Biol	2018
28973887	Cross-activating c-Met/Î²1 integrin complex drives metastasis and invasive resistance in cancer.	Proc Natl Acad Sci U S A	2017
23307858	Gene expression profile identifies tyrosine kinase c-Met as a targetable mediator of antiangiogenic therapy resistance.	Clin Cancer Res	2013
23750318	Mechanisms of evasive resistance to anti-VEGF therapy in glioblastoma.	CNS Oncol	2013
22789536	VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complex.	Cancer Cell	2012
21211535	Soluble E-cadherin promotes cell survival by activating epidermal growth factor receptor.	Exp Cell Res	2011
19690143	Fyn and SRC are effectors of oncogenic epidermal growth factor receptor signaling in glioblastoma patients.	Cancer Res	2009
18359864	Matrix metalloproteinase-2 regulates vascular patterning and growth affecting tumor cell survival and invasion in GBM.	Neuro Oncol	2008
19074867	p53 Small-molecule inhibitor enhances temozolomide cytotoxic activity against intracranial glioblastoma xenografts.	Cancer Res	2008
19022055	Chapter 3. Bone marrow-derived vascular progenitors and proangiogenic monocytes in tumors.	Methods Enzymol	2008
18328425	HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion.	Cancer Cell	2008
16912159	Mammalian target of rapamycin inhibition promotes response to epidermal growth factor receptor kinase inhibitors in PTEN-deficient and PTEN-intact glioblastoma cells.	Cancer Res	2006
17090670	Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target.	Proc Natl Acad Sci U S A	2006
15908427	Differential induction of glioblastoma migration and growth by two forms of pleiotrophin.	J Biol Chem	2005
16282176	Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.	N Engl J Med	2005
14631378	Upregulation of tissue inhibitor of metalloproteinases (TIMP)-2 promotes matrix metalloproteinase (MMP)-2 activation and cell invasion in a human glioblastoma cell line.	Lab Invest	2004
12700671	Identification of molecular subtypes of glioblastoma by gene expression profiling.	Oncogene	2003
12083807	Expression of the liver form of arginase in erythrocytes.	Mol Genet Metab	2002
11385319	A multiethnic study of Delta32ccr5 and ccr2b-V64I allele distribution in four Los Angeles populations.	Diagn Mol Pathol	2001
9587962	In vitro methionine oxidation of recombinant human leptin.	Pharm Res	1998
7626004	Mistranslation of a TGA termination codon as tryptophan in recombinant platelet-derived growth factor expressed in Escherichia coli.	Biochem J	1995

1 - 23 of 23

Nazanin Tatari

McMaster University

Career Start Year 2015

Number of shared co-authors 0

Jin-Ku Lee

Seoul National University, College of Medicine

Career Start Year 2010

Number of shared co-authors 4

Donggeon Kim

Institute for Refractory Cancer Research, Samsung Medical Center

Career Start Year 2009

Number of shared co-authors 4

Verlene Henry

The MD Anderson Cancer Center

Career Start Year 2005

Number of shared co-authors 0

Khatri Latha

Baylor College of Medicine

Career Start Year 2005

Number of shared co-authors 2

Joshua C Anderson

University of Alabama at Birmingham

Career Start Year 2005

Number of shared co-authors 0

Anita B Hjelmeland

University of Alabama at Birmingham

Career Start Year 2004

Number of shared co-authors 0

Bo Hu

Northwestern University Feinberg School of Medicine

Career Start Year 2003

Number of shared co-authors 3

Mirko H H Schmidt

Institute of Anatomy, Technische Universitat Dresden School of Medicine

Career Start Year 2001

Number of shared co-authors 2

Yong Jae Shin

Cancer Stem Cell Research Center, Samsung Biomedical Research Institute

Career Start Year 2001

Number of shared co-authors 4

Jeongwu Lee

Lerner Research Institute, Cleveland Clinic

Career Start Year 2001

Number of shared co-authors 5

Christopher D Willey

University of Alabama at Birmingham

Career Start Year 2000

Number of shared co-authors 2

Annette T Byrne

Royal College of Surgeons in Ireland (RCSI)

Career Start Year 1999

Number of shared co-authors 1

Agnieszka Bronisz

Mossakowski Medical Research Institute, Polish Academy of Sciences

Career Start Year 1999

Number of shared co-authors 1

Yuhui Yang

Xuanwu Hospital, Capital Medical University

Career Start Year 1999

Number of shared co-authors 0

Krishna P Bhat

Department of Neurosurgery at the University of Texas MD Anderson Cancer Center

Career Start Year 1998

Number of shared co-authors 3

Timothy E Van Meter

Virginia Commonwealthy University

Career Start Year 1998

Number of shared co-authors 3

Christopher Ryan Miller

University of Illinois at Urbana-Champaign

Career Start Year 1996

Number of shared co-authors 7

Dimpy Koul

The University of Texas MD Anderson Cancer Center

Career Start Year 1996

Number of shared co-authors 0

Shi-Yuan Cheng

Northwestern University Feinberg School of Medicine

Career Start Year 1996

Number of shared co-authors 7

Gurpreet S Kapoor

Collegeville

Career Start Year 1995

Number of shared co-authors 0

H-J Su Huang

Regeneron Pharmaceuticals Inc.

Career Start Year 1994

Number of shared co-authors 4

Suyun Huang

Virginia Commonwealth University

Career Start Year 1993

Number of shared co-authors 0

Jeremy N Rich

UPMC Hillman Cancer Center, University of Pittsburgh Medical Center

Career Start Year 1992

Number of shared co-authors 11

Donald M O'Rourke

Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania

Career Start Year 1991

Number of shared co-authors 3

Howard A Fine

Meyer Cancer Center

Career Start Year 1990

Number of shared co-authors 7

Oliver B??gler

American Association for Cancer Research, Henry Ford Hospital, Ludwig Institute for Cancer Research, National Cancer Institute, Salk Institute for Biological Studies, University of Cambridge, University of Texas MD Anderson Cancer Center, Virginia Commonwealth University

Career Start Year 1990

Number of shared co-authors 3

Wei Zhang

The University of Texas MD Anderson Cancer Center

Career Start Year 1988

Number of shared co-authors 4

Erwin G Van Meir

Heersink School of Medicine, University of Alabama at Birmingham

Career Start Year 1984

Number of shared co-authors 9

Wai-Kwan Alfred Yung

University of Texas M.D. Anderson Cancer Center